Literature DB >> 21190110

Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class B.

Shintaro Kuroda1, Hirotaka Tashiro, Tsuyoshi Kobayashi, Akihiko Oshita, Hironobu Amano, Hideki Ohdan.   

Abstract

BACKGROUND: The appropriate surgical approach for hepatocellular carcinoma (HCC) patients of Child-Pugh class B is unclear. The aim of this study was to clarify the prognostic factors after hepatectomy in Child-Pugh class B patients and to delineate the selection criteria for hepatectomy.
METHODS: One hundred fifty patients of Child-Pugh class B who underwent hepatectomy were enrolled in this retrospective study (Hx group). Univariate and multivariate analyses were performed to identify prognostic factors. The prognosis was compared with that of 23 patients of Child-Pugh class B who underwent liver transplantation (LT group).
RESULTS: The overall survival rate of the Hx group was significantly worse than that of the LT group (5-year survival: 36.0 vs. 78.3%, p = 0.001). In multivariate analyses, diabetes mellitus (p = 0.011), preoperative total bilirubin level ≥ 1.5 mg/dl (p = 0.038), and Child-Pugh score of 8 or 9 (p = 0.038) were independent prognostic factors. Although the overall 5-year survival rate of patients with none of the three adverse prognostic factors was only 50.3%, that of patients with one or more adverse prognostic factors was only 27.2% (p = 0.001).
CONCLUSIONS: Hepatectomy may be the optimal initial treatment for HCC patients classified as Child-Pugh class B and without any adverse prognostic factors.

Entities:  

Mesh:

Year:  2011        PMID: 21190110     DOI: 10.1007/s00268-010-0929-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s.

Authors:  Z Y Tang; Y Q Yu; X D Zhou
Journal:  Semin Surg Oncol       Date:  1993 Jul-Aug

3.  Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.

Authors:  Shinichi Ueno; Gen Tanabe; Kenshuke Nuruki; Makoto Oketani; Yasuji Komorizono; Hirohumi Hokotate; Yoshihiko Fukukura; Yoshirou Baba; Yasuhiro Imamura; Takashi Aikou
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

4.  Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Hideki Nakahara; Toshiyuki Itamoto; Koji Katayama; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

7.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

Authors:  J A Davila; R O Morgan; Y Shaib; K A McGlynn; H B El-Serag
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection.

Authors:  Y Ikeda; M Shimada; H Hasegawa; T Gion; K Kajiyama; K Shirabe; K Yanaga; K Takenaka; K Sugimachi
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

9.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

10.  Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report.

Authors:  Yuichi Torisu; Kenji Ikeda; Masahiro Kobayashi; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Yusuke Kawamura; Hiromi Yatsuji; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Journal:  Hepatol Res       Date:  2007-07       Impact factor: 4.288

View more
  8 in total

1.  Correct indication for surgery can prevent postoperative ascites in cirrhotic patients affected by hepatocellular carcinoma.

Authors:  Isidoro Di Carlo; Adriana Toro
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

2.  Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas.

Authors:  Masakazu Hashimoto; Hirotaka Tashiro; Tsuyoshi Kobayashi; Shintaro Kuroda; Michinori Hamaoka; Hideki Ohdan
Journal:  Langenbecks Arch Surg       Date:  2017-05-22       Impact factor: 3.445

3.  Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country.

Authors:  Danijel A Galun; Predrag Bulajic; Marinko Zuvela; Dragan Basaric; Tatjana Ille; Miroslav N Milicevic
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

4.  Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.

Authors:  Jin Hean Koh; Darren Jun Hao Tan; Yuki Ong; Wen Hui Lim; Cheng Han Ng; Phoebe Wen Lin Tay; Jie Ning Yong; Mark D Muthiah; Eunice X Tan; Ning Qi Pang; Beom Kyung Kim; Nicholas Syn; Alfred Kow; Brian K P Goh; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 8.265

Review 5.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

6.  Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.

Authors:  Qingshan Li; Yue Wang; Tao Ma; Yi Lv; Rongqian Wu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

Review 7.  Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Chikara Shirata; Meguri Tanimoto; Takeaki Ishizawa; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Nicolas Demartines; Emilie Uldry; Norihiro Kokudo; Nermin Halkic
Journal:  Liver Cancer       Date:  2019-07-26       Impact factor: 11.740

8.  CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis.

Authors:  Jing Sun; Aimin Zhang; Wengang Li; Quan Wang; Jia Wang; Yuze Fan; Yingzhe Sun; Dong Li; Dan Zhang; Xuezhang Duan
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.